Regulatory Writer Acceleration Residency (RWA Residency) is a unique opportunity for those interested in becoming a regulatory writer. Learn from a team with a proven track record of success in various disciplines of regulatory writing. We invite you to join us as we continue to develop the next generation of regulatory writers.
During the residency, colleagues will embark on a two-year curriculum, which will teach the skills needed to lead regulatory writing projects while increasing exposure to documents that drive drug development. As a services organization, Certara Synchrogenix’s program offers the opportunity to develop skills necessary to work directly with our sponsors within the initial year of employment. Opportunities exist in the clinical, nonclinical, and pharmacovigilance disciplines.
The ideal candidates (hiring into this program every six months) will have the opportunity to participate in a mentor-driven training program that accelerates the transition to leading the writing efforts for regulatory documents.
Certara Synchrogenix has been a leader in regulatory writing for over 30 years, and we are investing in the next generation of regulatory writers!
Applications are now being accepted for our January 2022 class. Click here to view the position description and apply. Recruitment requirements include a writing sample, a one hour writing exercise, a job matching survey, and team interviews.
The deadline for application submission is October 15.